In This Article We Will Know AboutLunaphore’s Exciting Partnership with Discovery Life Sciences Promises to Transform Clinical Research
Lunaphore Partners with Discovery Life Sciences to Revolutionize Spatial Biology Research
Lunaphore, a leading provider of spatial biology technology, has entered into a groundbreaking partnership with Discovery Life Sciences, a global leader in biospecimen solutions and lab services. This collaboration will see Lunaphore’s state-of-the-art COMET™ platform integrated into Discovery Life Sciences’ extensive suite of services, supporting biopharmaceutical and clinical research worldwide.
The Power of Lunaphore COMET™ Technology
The Lunaphore COMET™ platform is recognized as one of the most advanced spatial biology systems on the market. As the only fully automated, high-throughput, hyperplex platform available today, COMET™ offers unparalleled tissue profiling capabilities. With the addition of this platform to Discovery Life Sciences’ offerings, researchers now have access to a powerful tool designed to accelerate breakthroughs in multiple fields of medicine, including:
– Immuno-oncology
– Immunology
– Neuroscience
– Infectious diseases
COMET’s ability to provide precise and multidimensional spatial insights enables scientists to dive deeper into the complexities of these diseases, paving the way for improved research outcomes.
Advancing Clinical Research and Translational Medicine ( Lunaphore’s Exciting Partnership with Discovery Life Sciences Promises to Transform Clinical Research )
The integration of Lunaphore’s COMET™ technology with Discovery Life Sciences’ scientific expertise is expected to enhance the precision, speed, and accuracy of research across all phases of drug and biomarker development. This partnership is aimed at improving patient stratification, biomarker discovery, and translational medicine—all key areas in the race to develop next-generation therapies.
Discovery will be offering **COMET Hyperplex Immunofluorescence Services**, enabling the development of hyperplex assays for clinical trials. These services promise to deliver high-quality spatial biology data, which is crucial for advanced drug development.
Leadership Comments on the Partnership
Greg Herrema, CEO of Discovery Life Sciences, expressed his enthusiasm for the collaboration, stating:
> “We are thrilled to expand our specialist lab services with Lunaphore COMET Hyperplex Immunofluorescence Services. This collaboration, which combines COMET with our expertise in molecular pathology, holds immense potential to further biomedical research. Our pharmaceutical clients will now have access to cutting-edge hyperplex assays that meet strict regulatory standards, including CLIA compliance.”
Matt McManus, President of Bio-Techne’s Diagnostics & Genomics Segment, also emphasized the strategic importance of the partnership:
> “Discovery Life Sciences stands out as a pioneering global leader, delivering COMET’s cutting-edge capabilities to clients across the U.S., Europe, and APAC. This partnership aligns with Bio-Techne’s mission to drive medical research forward and improve patient outcomes. I am excited to witness how rapidly COMET will advance spatial biology applications in clinical trials.”
A New Era for Spatial Biology in Clinical Trials
As the demand for spatial biology grows in clinical research, the partnership between Lunaphore and Discovery Life Sciences is positioned to provide biopharma companies with the tools and services they need to succeed. With the integration of COMET™, researchers will now be able to conduct high-dimensional spatial analysis with unprecedented accuracy and efficiency, ultimately accelerating the pace of biomedical discoveries and improving patient outcomes.
This collaboration sets the stage for a new era of innovation in spatial biology, offering researchers the opportunity to leverage cutting-edge technology to uncover the biological complexities behind some of the most challenging diseases.
Conclusion
The partnership between Lunaphore and Discovery Life Sciences represents a significant milestone in the advancement of spatial biology research. With Lunaphore’s COMET™ platform and Discovery’s deep expertise, this collaboration is poised to transform the landscape of clinical trials, enabling pharmaceutical companies to develop better therapies faster. This strategic alliance marks a new chapter in the future of biomedical research and patient care.
Supply hyperlink